Promising new test spots hidden virus after transplant

NCT ID NCT07181330

First seen Jun 25, 2026 · Last updated Jun 26, 2026 · Updated 1 time

Summary

This study tested a new blood test that looks for a tiny piece of the CMV virus's genetic material (a microRNA) in 60 patients who had a stem cell transplant. The goal was to see if this test could detect CMV reactivation earlier or more accurately than the standard DNA test. Researchers used stored blood samples and compared the new test results to the standard method.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
SE-SPTM-PCR microRNA assay (a blood test)
What this could lead to
If successful, this test could provide a more sensitive way to detect CMV reactivation early after stem cell transplant, potentially improving patient outcomes.
What could go wrong
This is a small, retrospective study using stored samples, so results may not apply to all patients. The test is still experimental and needs larger prospective studies to confirm its usefulness.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • The First Affiliated Hospital of Fujian Medical University

    Fuzhou, Fujian, 350001, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.